Bank of America Corporation »

Atea Pharmaceuticals shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $743k 244k 3.05
2023-09-30 $289k 96k 3.00
2023-06-30 $383k 103k 3.74
2023-03-31 $457k 137k 3.35
2022-12-31 $839k 174k 4.81
2022-06-30 $321k 45k 7.09
2021-12-31 $1.1M 124k 8.94
2021-06-30 $1.4M 65k 21.46
2021-03-31 $1.5M 24k 61.72
2020-12-31 $593k 14k 41.78